Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Thermo Fisher Scientific (TMO)

Thermo Fisher Q1 revenue rises 6% to $11.01 billion; adjusted EPS $5.44

Positive Impact 3 of 5 earnings Written later

Thermo Fisher reported first-quarter 2026 results for the quarter ended March 28, 2026, with revenue up 6% to $11.01 billion and GAAP diluted EPS up 11% to $4.43. Organic revenue growth was 1%, and the company said it completed the Clario acquisition and repurchased $3.0 billion of stock during the quarter. The company said it will provide updated 2026 guidance on its earnings call, so the filing itself contains no new guidance.

Key points

  • Revenue grew 6% to $11.01 billion from $10.36 billion a year earlier; organic revenue growth was 1%.
  • GAAP diluted EPS was $4.43, up 11%; adjusted EPS was $5.44, up 6%.
  • GAAP operating margin was 16.9%, compared with 16.6%; adjusted operating margin was 21.8%, compared with 21.9%.
  • Updated 2026 guidance will be given on the April 23, 2026 earnings call at 8:30 a.m. Eastern Time.

The filing

CompanyThermo Fisher Scientific (TMO)
Form8-K, current report
Filed with the SECApr 23, 2026, 6:03 AM ET
Accession number0000097745-26-000086

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.